Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast Cancer. (2023)
Attributed to:
MRC Centre for Reproductive Health at the University of Edinburgh
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.6004/jnccn.2022.7065
PubMed Identifier: 36634607
Publication URI: http://europepmc.org/abstract/MED/36634607
Type: Journal Article/Review
Volume: 21
Parent Publication: Journal of the National Comprehensive Cancer Network : JNCCN
Issue: 1
ISSN: 1540-1405